The dementia charity will be interested in further stem cell research, it said.
Its comments came after scientists revealed stem cells were needed to replace neurones that have been lost in dementia patients.
The cells – which can be moulded by scientists to become any type of cell in the body – also help to revitalise stressed cells surrounding them in the body.
Advancing the research was crucial to finding a cure for neurodegenerative conditions, including Alzheimer’s and Parkinson’s disease.
Dementia UK’s Chief Admiral Nurse, Dr Hilda Hayo, said: “Dementia UK welcomes anything that might lead to successful treatment of dementia and we will be interested to see the results of further stem cell study.
“However, a cure for dementia is still a long way off and so it is imperative that families affected by dementia are offered the appropriate post-diagnostic care, such as that offered by specialist dementia Admiral Nurse.”
Stem cell treatments would help the body to replace broken neurones, the study scientists said.
Aubrey de Grey, from research charity SENS Research Foundation, said: “Especially at late stages, the main chronic neurodegenerative conditions of old age are characterised by the loss of neurones that the body does not replace.
“We need stem cell therapies to do that replacement.”
De Grey’s comments came after scientists uncovered a way to regenerate diseased or lost tissue. The reveal could unravel new treatments for cancer patients.
Scientists from the University of Michigan built on previous stem cell research.
Previously, skin cells had been taken, developing into stem cells, and then transformed into whichever new cell scientists were researching.
But, the researchers found a way to cut out the middle-man, and transform skin cells into other types of cells.
Co-author of the research, Nax Wicha, said: “This provides a blueprint that has important implications for cancer, in that we think cancer stem cells may arise from normal stem cells via similar reprogramming pathways.
“This work also has important implications for regenerative medicine and tissue engineering, since it provides a blueprint for generating any desired cell type.”
About 850,000 people in the UK have dementia, according to the Alzheimer’s Society.
By 2025, it’s estimated than the number of dementia patients will top one million in the UK.